BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Deals

Spirogen, Roche deal

Roche's Genentech Inc. unit and Spirogen partnered to discover and develop antibody drug conjugates (ADCs) as anticancer therapeutics using Spirogen's...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >